Neuromyelitis optica (NMOSD) trials in United Kingdom

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

  Where

  London

  Age

  2 years to 11 years

  People

  8 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT05199688 · EU 2023-507817-85-00
• No phaseNot yet taking people in United Kingdom
  Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool

  Where

  London

  Age

  16 years and over

  People

  180

  Run by

  King's College London

  See details and how to joinNCT07704294
• No phaseTaking people
  Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

  Where

  London

  People

  75 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT06312644
• Phase 2Taking people
  Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

  Where

  Birmingham, London

  Age

  2 years to 17 years

  People

  15 worldwide

  Run by

  Amgen

  See details and how to joinNCT05549258 · EU 2023-510007-22-00